Endo Wields The Axe Again As It Eyes $95m Annual Savings

Two US Manufacturing Sites To Close; Other Measures Taken

 
• By Dean Rudge
  
MoneyStack
Endo is eyeing up to $95m in pre-tax cash savings through the measures • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business